These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16472735)

  • 1. Selectivity and promiscuity in Eph receptors.
    Haramis AP; Perrakis A
    Structure; 2006 Feb; 14(2):169-71. PubMed ID: 16472735
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure and thermodynamic characterization of the EphB4/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity.
    Chrencik JE; Brooun A; Recht MI; Kraus ML; Koolpe M; Kolatkar AR; Bruce RH; Martiny-Baron G; Widmer H; Pasquale EB; Kuhn P
    Structure; 2006 Feb; 14(2):321-30. PubMed ID: 16472751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity.
    Koolpe M; Burgess R; Dail M; Pasquale EB
    J Biol Chem; 2005 Apr; 280(17):17301-11. PubMed ID: 15722342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and biophysical characterization of the EphB4*ephrinB2 protein-protein interaction and receptor specificity.
    Chrencik JE; Brooun A; Kraus ML; Recht MI; Kolatkar AR; Han GW; Seifert JM; Widmer H; Auer M; Kuhn P
    J Biol Chem; 2006 Sep; 281(38):28185-92. PubMed ID: 16867992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of EphB and ephrin-B expression in rhabdomyosarcoma.
    Berardi AC; Marsilio S; Rofani C; Salvucci O; Altavista P; Perla FM; Diomedi-Camassei F; Uccini S; Kokai G; Landuzzi L; McDowell HP; Dominici C
    Anticancer Res; 2008; 28(2A):763-9. PubMed ID: 18507018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4.
    Duggineni S; Mitra S; Noberini R; Han X; Lin N; Xu Y; Tian W; An J; Pasquale EB; Huang Z
    Biochem Pharmacol; 2013 Feb; 85(4):507-13. PubMed ID: 23253822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR structure and dynamics of human ephrin-B2 ectodomain: the functionally critical C-D and G-H loops are highly dynamic in solution.
    Ran X; Qin H; Liu J; Fan JS; Shi J; Song J
    Proteins; 2008 Aug; 72(3):1019-29. PubMed ID: 18300229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting receptor tyrosine kinase EphB4 in cancer therapy.
    Chen Y; Zhang H; Zhang Y
    Semin Cancer Biol; 2019 Jun; 56():37-46. PubMed ID: 28993206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell lines.
    Fox BP; Tabone CJ; Kandpal RP
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1263-72. PubMed ID: 16516143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of angiogenesis by Eph-ephrin interactions.
    Kuijper S; Turner CJ; Adams RH
    Trends Cardiovasc Med; 2007 Jul; 17(5):145-51. PubMed ID: 17574121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling EphB4-EphrinB2 protein-protein interaction using flexible docking of a short linear motif.
    Ciemny MP; Kurcinski M; Blaszczyk M; Kolinski A; Kmiecik S
    Biomed Eng Online; 2017 Aug; 16(Suppl 1):71. PubMed ID: 28830442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of EphA receptor tyrosine kinases and ephrinA ligand expression to EphB-ephrinB in vascularized corneas.
    Kojima T; Chung TY; Chang JH; Sayegh R; Casanova FH; Azar DT
    Cornea; 2007 Jun; 26(5):569-78. PubMed ID: 17525654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4).
    Lafleur K; Huang D; Zhou T; Caflisch A; Nevado C
    J Med Chem; 2009 Oct; 52(20):6433-46. PubMed ID: 19788238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel Eph receptor tyrosine kinase, EphA10, expressed in testis.
    Aasheim HC; Patzke S; Hjorthaug HS; Finne EF
    Biochim Biophys Acta; 2005 May; 1723(1-3):1-7. PubMed ID: 15777695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
    Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG
    J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of pterygium: role of Eph receptors and ligand ephrins.
    Garg P
    Can J Ophthalmol; 2009 Apr; 44(2):138-40. PubMed ID: 19491945
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative integromics on Eph family.
    Katoh M; Katoh M
    Int J Oncol; 2006 May; 28(5):1243-7. PubMed ID: 16596241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
    Noren NK; Foos G; Hauser CA; Pasquale EB
    Nat Cell Biol; 2006 Aug; 8(8):815-25. PubMed ID: 16862147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis.
    Zhao C; Irie N; Takada Y; Shimoda K; Miyamoto T; Nishiwaki T; Suda T; Matsuo K
    Cell Metab; 2006 Aug; 4(2):111-21. PubMed ID: 16890539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ephrin-B2 immunoreactivity distribution in adult mouse brain.
    Migani P; Bartlett C; Dunlop S; Beazley L; Rodger J
    Brain Res; 2007 Nov; 1182():60-72. PubMed ID: 17945206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.